> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Amneal’s Brekiya Approved for Migraines
- URL: https://www.fdaweb.com/amneals-brekiya-approved-for-migraines/
- Published: 2025-05-15T12:00:00.000Z
- Updated: 2026-09-14T15:12:02.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5159186

FDA has approved Amneal Pharmaceuticals’ Brekiya (dihydrogotamine mesylate) injection for the acute treatment of migraine and cluster headaches in adults. The company [says](https://www.globenewswire.com/news-release/2025/05/15/3082078/0/en/Amneal-Receives-U-S-FDA-Approval-for-Brekiya-dihydroergotamine-mesylate-injection-for-the-Acute-Treatment-of-Migraine-and-Cluster-Headaches-in-Adults.html?ref=fdaweb.com) Brekiya is the only dihydrogotamine mesylate autoinjector that allows patients to self-administer the same medication used in hospitals.